Clinical Trial

The Effect of Interventions for Health Behaviors in Hypertensive Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 20, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
Hypertension is a major risk factor for cardiovascular disease, chronic kidney disease, and premature death worldwide. With an aging population and changes in dietary patterns and lifestyles, the prevalence of hypertension is rising globally, especially in developing countries. Hypertension is the most common chronic disease and a growing public health problem in China. A recent study estimated the prevalence of hypertension to be 28.56 % ± 10.44 %, ranging from 14.28% to 44.28% among the Chinese population aged over 15 years. The PRECEED-PROCEDE model provides a framework to help health planners and policymakers design effective health interventions based on evaluation and analysis of situations. This model has been used in different recent studies related to behavioral change. The study aims to examine the effectiveness of interventions for health behaviors in hypertensive patients based on the PRECEDE-PROCEED model.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-11.
Trial Details
NCT Number NCT06640751
Lead Sponsor Nanjing Medical University
Conditions Hypertension, Health Behavior, Public Health
Enrollment 240 participants
Start Date 2024-10-01
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2024-11-20